Ligand Pharmaceuticals

LGND

Börsenwert 6,18 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
401	APFP 401 Action Point Financial Planning Grand Rapids, Michigan	2.528 $	+2.121 $	+9	Neu
402	AW 402 Avion Wealth The Woodlands, Texas	2.000 $	–	–	–
403	403 Fortitude Family Office Scottsdale, Arizona	1.580 $	+236 $	+1	+25 %
404	404 Gilpin Wealth Management Denver, Colorado	949 $	–	–	–
405	405 Prestige Wealth Management Group Flemington, New Jersey	949 $	+236 $	+1	+50 %
406	406 Rialto Wealth Management Syracuse, New York	949 $	+471 $	+2	+200 %
407	407 Ankerstar Wealth Leander, Texas	948 $	–	–	–
408	408 Blue Trust Inc Alpharetta, Georgia	948 $	–	–	–
409	409 Zions Bancorporation, National Association Salt Lake City, Utah	948 $	–	–	–
410	410 1620 Investment Advisors Plymouth, Massachusetts	948 $	+707 $	+3	Neu
411	411 Plante Moran Financial Advisors Southfield, Michigan	948 $	+707 $	+3	Neu
412	412 Creative Capital Management Investments San Diego, California	632 $	+471 $	+2	Neu
413	MWM 413 Mascoma Wealth Management Hanover, New Hampshire	632 $	+471 $	+2	Neu
414	414 Abound Wealth Management Franklin, Tennessee	317 $	–	–	–
415	415 GHP Investment Advisors Denver, Colorado	317 $	–	–	–
416	416 Clearstead Advisors Cleveland, Ohio	317 $	+236 $	+1	Neu
417	417 Davis Capital Management Jacksonville, Florida	316 $	+236 $	+1	Neu
418	418 Inspire Investing Meridian, Idaho	199 $	-213.950 $	-908	-100 %
419	419 Qube Research & Technologies (QRT) London, United Kingdom	–	-9,5 Mio. $	-47.659	Geschlossen
420	420 Arrowstreet Capital Boston, Massachusetts	–	-2,91 Mio. $	-14.564	Geschlossen
421	421 Jane Street New York	–	-3,04 Mio. $	-12.906	Geschlossen
422	422 Voloridge Investment Management Jupiter, Florida	–	-2,5 Mio. $	-12.543	Geschlossen
423	423 Walleye Capital New York	–	-2,43 Mio. $	-10.333	Geschlossen
424	424 Ishara Investments Los Angeles, California	–	-1,64 Mio. $	-8.200	Geschlossen
425	425 Marshall Wace London, United Kingdom	–	-1,5 Mio. $	-7.505	Geschlossen

Ligand Pharmaceuticals LGND Börsenwert 6,18 Mrd. $

Ligand Pharmaceuticals

LGND

Börsenwert 6,18 Mrd. $